SCHEMBL2849371

SCHEMBL2849371

C[C@@H](N)[C@@H](C)CC(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL787989 1.00
Hydrochloric Acid SCHEMBL26640128 0.97 GABRP (0.42)
Hydrochloric Acid SCHEMBL26640131 0.97 GABRP (0.42)
SCHEMBL6911838 0.83
SCHEMBL6911844 0.83
SCHEMBL304303 0.82 SLC22A6 (0.50)
SCHEMBL5077944 0.82 SLC22A6 (0.50)
SCHEMBL23964052 0.81
SCHEMBL398726 0.79 SLC7A5 (0.52)
SCHEMBL12648478 0.79 SLC7A5 (0.52)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111484963-A Process for producing L-amino acid 味之素株式会社 2020-08-04 CN disclosed
US-7785566-B2 Pharmaceutical compounds GE HEALTHCARE, INC. (NO) 2010-08-31 US disclosed
US-7763234-B2 Pharmaceutical compounds GE HEALTHCARE AS (NO) 2010-07-27 US disclosed
EP-1729823-B1 CONJUGATES OF ANGIOTENSIN PEPTIDIC ANALOGUES AND CHELATING AGENTS FOR DIAGNOSIS AND THERAPY GE HEALTHCARE AS (NO) 2009-11-04 EP disclosed
US-20070297979-A1 Pharmaceutical Compounds GE HEALTHCARE AS (NO) 2007-12-27 US disclosed
US-20070134155-A1 Pharmaceutical compounds AMERSHAM HEALTH AS (NO) 2007-06-14 US disclosed
CN-1925876-A Conjugates of angiotensin peptidic analogues and chelating agents for diagnosis and therapy GE HEALTHCARE AS (NO) 2007-03-07 CN disclosed
CN-1901941-A Conjugates of angiotensin ii and an imaging moiety GE MEDICAL SYST SA (NO) 2007-01-24 CN disclosed
EP-1729823-A2 CONJUGATES OF ANGIOTENSIN PEPTIDIC ANALOGUES AND CHELATING AGENTS FOR DIAGNOSIS AND THERAPY GE Healthcare AS (NO) 2006-12-13 EP disclosed
EP-1699495-A2 CONJUGATES OF ANGIOTENSIN II AND AN IMAGING MOIETY Amersham Health AS (NO) 2006-09-13 EP disclosed
WO-2005044313-A2 CONJUGATES OF ANGIOTENSIN II AND AN IMAGING MOIETY AMERSHAM HEALTH AS (NO) 2005-05-19 WO disclosed
EP-0835233-B1 COMPOSITION AND METHOD FOR STABILIZING RADIOLABELED ORGANIC COMPOUNDS NEN LIFE SCIENCE PROD INC (US) 2001-12-05 EP disclosed
EP-0972074-A1 A METHOD FOR IDENTIFYING THE SITE OF ACTION OF XENOBIOTIC CHEMICALS E.I. DU PONT DE NEMOURS & COMPANY INCORPORATED (US) 2000-01-19 EP disclosed
US-5843396-A Method for stabilizing radiolabeled organic compounds by adding a separate stabilizing compound NEN LIFE SCIENCE PRODUCTS, INC. (US) 1998-12-01 US disclosed
WO-1998038336-A1 A METHOD FOR IDENTIFYING THE SITE OF ACTION OF XENOBIOTIC CHEMICALS E.I. DU PONT DE NEMOURS AND COMPANY (US) 1998-09-03 WO disclosed
EP-0835233-A1 COMPOSITION AND METHOD FOR STABILIZING RADIOLABELED ORGANIC COMPOUNDS E.I. DU PONT DE NEMOURS AND COMPANY (US) 1998-04-15 EP disclosed
US-5738836-A Composition for stabilizing radiolabeled organic compounds E. I. DU PONT DE NEMOURS AND COMPANY (US) 1998-04-14 US disclosed
WO-1997001520-A1 COMPOSITION AND METHOD FOR STABILIZING RADIOLABELED ORGANIC COMPOUNDS E.I. DU PONT DE NEMOURS AND COMPANY (US) 1997-01-16 WO disclosed
US-4411881-A Composition and method for stabilizing radiolabeled compounds using thiocarbonylated diethylenetriamines NEW ENGLAND NUCLEAR CORPORATION (US) 1983-10-25 US disclosed
US-3956219-A DIVINYLBENZENE ELI LILLY AND COMPANY (US) 1976-05-11 US disclosed